Form 4 for RMD ResMed|
Accepted 2024-11-12 00:00:00 ET · period of report 2024-11-07 · accession 0001127602-24-027086 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-11-12 | 2024-11-11 | RMD | Farrell Michael J. | CEO | F - Tax | $252.38 | -8,781 | 461.2K | -2% | -$2.22M |
| D | 2024-11-12 | 2024-11-07 | RMD | Farrell Michael J. | CEO | S - Sale+OE | $246.26 | -14.7K | 464.3K | -3% | -$3.62M |
| D | 2024-11-12 | 2024-11-07 | RMD | Farrell Michael J. | CEO | M - OptEx | $84.98 | +14.7K | 478.9K | +3% | +$1.25M |
| D | 2024-11-12 | 2024-11-07 | RMD | Farrell Michael J. | CEO | M - OptEx | $0.00 | -14.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2024-11-11 | F | D | 3,452.90 | $252.38 | 455,472 | D | — | — | |
| 2 | Common | ResMed Common Stock | 2024-11-07 | S | D | 14,683 | $246.26 | 464,254 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $244.74 - $248.38 The price reported above reflects the weighted average sale price. |
| 3 | Common | ResMed Common Stock | 2024-11-11 | F | D | 2,226.86 | $252.38 | 458,925 | D | — | — | |
| 4 | Common | ResMed Common Stock | 2024-11-11 | F | D | 3,101.38 | $252.38 | 461,152 | D | — | — | |
| 5 | Common | ResMed Common Stock | 2024-11-07 | M | A | 14,683 | $84.98 | 478,937 | D | — | — | (F2) Includes 84.129 shares of ResMed stock purchased on October 31, 2024, through the ResMed Employee Stock Purchase Plan. |
| 6 | Derivative | ResMed Common Stock Options | 2024-11-07 | M | D | 14,683 | $0.00 | 0 | D | $84.98 · 2018-11-11 to 2024-11-16 | 14,683 ResMed Common Stock | (F9) Represents date options first become exercisable. Options vest 1/3 per year. |